FDA expands access to promising drug for pancreatic cancer
Summary
More patients will be able to take the pill while it is under review, as the agency cited the dire need for a drug to fight one of the most lethal cancers.
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.